Patrick Kwan
Patrick Kwan, director of Changzhou Trendi Medical Technology Co., Ltd, expert in neurologist, an academician of the Australian Academy of Health and Medical Sciences, a professor in the Department of Neuroscience at Monash University, Head of the Epilepsy Unit at Alfred Hospital, Melbourne, Australia, and director of the Chongqing Key Laboratory of Neurology.
Patrick Kwan graduated from the University of Nottingham in 1990 with a Bachelor of Medicine Sciences degree; in 1993, obtained Bachelor degrees in Medicine and Surgery from the University of Cambridge; received a Ph.D. degree from the University of Glasgow in 2001; in 2013, he was appointed as the Chair of Neurology at the University of Melbourne and the head of the Epilepsy Program at Royal Melbourne Hospital; in 2017, he was elected to the Australian Academy of Health and Medical Sciences, appointed as a professor of the Department of Neuroscience at Monash University and Director of Epilepsy at Alfred Hospital.
Patrick Kwan's research fields include applied basic science and clinical aspects, with emphasis on epidemiology, pharmacology, genetics and use of biomedical technology for personalised medicine.
Experience
2017 Professor of Neurology, Department of Neuroscience, Monash University
2017 Director of Epilepsy Unit, Melbourne Alfred Hospital
2018 Medical Research Future Fund (MRFF) Practitioner Researcher
2017 Honorary Professor, University of Melbourne, Royal Melbourne Hospital
2015 Adjunct Professor, Department of Electrical and Electronic Engineering, University of Melbourne
2018 Honorary Professor, Guangzhou Medical University
2018 Honorary Professor, First Affiliated Hospital of Sun Yat-sen University
2018 Guest Professor, Department of Medicine, Shanghai Jiao Tong University
2004 Honorary Clinical Associate Professor, Department of Medicine and Therapeutics, University of Hong Kong
Awards and Honors
Research Reviews
Patrick Kwan has been engaged in epilepsy treatment and research, especially focusing on the clinical pharmacology and pharmacogenomics research of antiepileptic drugs. His research has shaped the modern understanding of the prognosis of epilepsy and laid the foundation for the first global consensus definition of drug-resistant epilepsy published by the International Anti-Epilepsy Alliance (ILAE) task force he chaired in 2010.
Publishes
As of March 2021, Patrick Kwan has published more than 260 SCI papers, as the first or corresponding author in New England Journal of Medicine, The Lancet Neurology, Nature Genetics, Brain, JAMA Neurology, Neurology and other medical journals, more than 22000 academic citations. As the first author, published an article on the prognosis of epilepsy in the New England Journal of Medicine. It is the most cited clinical research article in epilepsy research since records (more than 4800 citations).
